BindingDB logo
myBDB logout

null

SMILES: NCCc1ccc(cc1)C(=O)NCC(=O)N1CCN(CC(O)=O)C(=O)C1

InChI Key: InChIKey=KOURPRNCLQXUJV-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50062787   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Integrin alpha-IIb/beta-3


(Homo sapiens (Human))
BDBM50062787
PNG
((4-{2-[4-(2-Amino-ethyl)-benzoylamino]-acetyl}-2-o...)
Show SMILES NCCc1ccc(cc1)C(=O)NCC(=O)N1CCN(CC(O)=O)C(=O)C1
Show InChI InChI=1S/C17H22N4O5/c18-6-5-12-1-3-13(4-2-12)17(26)19-9-14(22)20-7-8-21(11-16(24)25)15(23)10-20/h1-4H,5-11,18H2,(H,19,26)(H,24,25)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.60n/an/an/an/an/an/a



Takeda Chemical Industries, Ltd.

Curated by ChEMBL


Assay Description
Ability to inhibit binding of biotin-labeled human fibrinogen to immobilized fibrinogen receptor purified from human erythroleukemia(HEL) cells.


J Med Chem 41: 489-502 (1998)


Article DOI: 10.1021/jm970235u
BindingDB Entry DOI: 10.7270/Q2571B4W
More data for this
Ligand-Target Pair
Integrin alpha-IIb/beta-3


(Homo sapiens (Human))
BDBM50062787
PNG
((4-{2-[4-(2-Amino-ethyl)-benzoylamino]-acetyl}-2-o...)
Show SMILES NCCc1ccc(cc1)C(=O)NCC(=O)N1CCN(CC(O)=O)C(=O)C1
Show InChI InChI=1S/C17H22N4O5/c18-6-5-12-1-3-13(4-2-12)17(26)19-9-14(22)20-7-8-21(11-16(24)25)15(23)10-20/h1-4H,5-11,18H2,(H,19,26)(H,24,25)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 150n/an/an/an/an/an/a



Takeda Chemical Industries, Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of human platelets by 50% in vitro.


J Med Chem 41: 489-502 (1998)


Article DOI: 10.1021/jm970235u
BindingDB Entry DOI: 10.7270/Q2571B4W
More data for this
Ligand-Target Pair
Integrin alpha-IIb/beta-3


(Homo sapiens (Human))
BDBM50062787
PNG
((4-{2-[4-(2-Amino-ethyl)-benzoylamino]-acetyl}-2-o...)
Show SMILES NCCc1ccc(cc1)C(=O)NCC(=O)N1CCN(CC(O)=O)C(=O)C1
Show InChI InChI=1S/C17H22N4O5/c18-6-5-12-1-3-13(4-2-12)17(26)19-9-14(22)20-7-8-21(11-16(24)25)15(23)10-20/h1-4H,5-11,18H2,(H,19,26)(H,24,25)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 180n/an/an/an/an/an/a



Takeda Chemical Industries, Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of guinea pig platelets by 50% in vitro


J Med Chem 41: 489-502 (1998)


Article DOI: 10.1021/jm970235u
BindingDB Entry DOI: 10.7270/Q2571B4W
More data for this
Ligand-Target Pair